Lazard Ltd. (0UB6)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 36.87 |
|---|---|
| 52-week range | 34.30 – 58.38 |
| Return, 1 month / 3 months | +0.0% / −12.0% |
| Return, 1 year / 3 years | −20.0% / +43.1% |
| Trend | Below its 200-day average |
| RSI (14) | 48 |
| Volatility (1 year) | 50.5% |
| Worst drawdown (1 year) | -39.7% |
| Average daily value traded | 0.00M USD |
| Dividend yield | 5.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lazard Ltd. is a financial advisory and asset management firm. It advises corporations, governments and institutions on mergers, acquisitions, restructurings and other strategic matters, and its asset management arm runs investment portfolios for institutional and individual clients across equity, fixed income and alternative strategies. The firm is based in New York and operates through offices in many countries, serving clients around the world from its advisory and asset management businesses.
The shares are listed on the London Exchange in UK under the code 0UB6, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lazard Ltd. (0UB6) trades on the London Exchange in UK. It last closed at USD 36.87 on 23 October 2026.
Its price-based Market X-Ray is 27 out of 100 (a weak price profile), ranking 3,196 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.0% and over the last three months it fell 12.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.1% | ||
| From 52-week high | -36.6% | ||
| Momentum | 20 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.0% | ||
| 6-month return | -22.6% | ||
| 12-month return, skipping the last month | -20.1% | ||
| Stability (higher is calmer) | 29 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.7% | ||
| Liquidity | 9 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M USD | ||
| Zero-volume days | 5.0% | ||
| Income | 82 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.4% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +0.0% |
| 3 months | −12.0% |
| 6 months | −22.6% |
| 1 year | −20.0% |
| 3 years | +43.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 39.73 / 44.48 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 1.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Aug 2026 | USD 0.5000 |
| 11 May 2026 | USD 0.5000 |
| 9 Feb 2026 | USD 0.5000 |
| 3 Nov 2025 | USD 0.5000 |
| 4 Aug 2025 | USD 0.5000 |
| 2 May 2025 | USD 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.